development dysplasia of hip
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Consent to join the study and obtain informed consent; 2) The age ranged from 2 to 7 years (inclusive); 3) American Society of anesthesiologists (ASA) grade I-II; 4) Children diagnosed as developmental dysplasia of the hip undergoing open reduction, pelvic osteotomy and femoral osteotomy;
Exclusion criteria
Exclusion criteria: 1) Coagulation dysfunction or anticoagulant therapy; 2) Spinal deformity; 3) The puncture site had a history of infection; 4) Allergy to ropivacaine; 5) Neuromuscular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CHEOPS scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| sufentanil dosage;Incidence of intraoperative hypotension;Incidence of postoperative hypotension;Incidence of bradycardia;Incidence of pruritus;Incidence of vertigo; | — |
Countries
China
Contacts
Department of Anesthesiology, Shanghai Sixth People's Hospital